Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study

Volume: 6, Issue: 4, Pages: 564 - 567
Published: May 7, 2018
Abstract
Peyronie's disease (PD) is a common condition which results in penile curvature making sexual intercourse difficult or impossible. Collagenase clostridium histolyticum (CCH) is the first licensed drug for the treatment of PD and is indicated in patients with palpable plaque and curvature deformity of at least 30° of curvature. However, only few monocentric studies are available in the current literature and this is the first national...
Paper Details
Title
Collagenase clostridium histolyticum for the treatment of Peyronie's disease: a prospective Italian multicentric study
Published Date
May 7, 2018
Volume
6
Issue
4
Pages
564 - 567
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.